Annual report pursuant to Section 13 and 15(d)

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)

v3.21.1
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Income Tax Disclosure [Abstract]    
Amortization $ 586,174 $ 868,974
Net operating loss carryforward 20,671,683 16,053,316
Allowance for doubtful accounts 403,991 1,559,750
Charitable contributions 624 623
Stock options 971,860 970,496
Accrued liabilities 312,419 467,086
HHS Provider Relief Funds 1,175,790
R&D credit carryforward 220,431
Business interest expense 0 2,323,330
Deferred state tax asset 5,117,347 1,428,268
Total deferred income tax assets 29,460,319 23,671,843
Depreciation (1,498,698) (1,578,355)
Total deferred income tax liabilities (1,498,698) (1,578,355)
Deferred tax asset, net 27,961,621 22,093,488
Less: valuation allowance (27,961,621) (22,093,488)
Net deferred tax assets